Pharmaron Beijing Co., Ltd. (HKG:3759)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
21.82
+1.22 (5.92%)
Apr 28, 2026, 4:08 PM HKT
59.50%
Market Cap 60.16B
Revenue (ttm) 15.69B
Net Income (ttm) 1.85B
Shares Out n/a
EPS (ttm) 1.05
PE Ratio 32.49
Forward PE 25.03
Dividend 0.22 (1.00%)
Ex-Dividend Date Jul 4, 2025
Volume 13,819,475
Average Volume 6,327,065
Open 20.94
Previous Close 20.60
Day's Range 20.88 - 22.16
52-Week Range 12.88 - 30.12
Beta 0.91
RSI 61.86
Earnings Date Mar 30, 2026

About Pharmaron Beijing

Pharmaron Beijing Co., Ltd., together with its subsidiaries, operates as a pharmaceutical research and development service platform in North America, Europe, the Mainland China, Asia, and internationally. It operates through five segments: Laboratory Services; Chemical and Formulation Process Development and Manufacturing Services; Clinical Research Services; Macromolecule and Cell and Gene Therapy Services; and Others. The company offers laboratory chemistry and biological science services, including small molecule chemical drugs, oligonucleot... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2004
Employees 25,088
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 3759
Full Company Profile

Financial Performance

In 2025, Pharmaron Beijing's revenue was 14.10 billion, an increase of 14.82% compared to the previous year's 12.28 billion. Earnings were 1.66 billion, a decrease of -7.22%.

Financial numbers in CNY

News

There is no news available yet.